Clinical trial
Methods Study to Characterize Early Indicators of Weight Loss in People
NCT00383253 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00383253 |
|---|---|
| Title | Methods Study to Characterize Early Indicators of Weight Loss in People |
| Official title | A Randomized, Open-Label, Parallel Group, Fixed Energy Deficit Methodology Trial to Characterize Early Efficacy Biomarkers During Treatment of Obesity in Adult, Obese, Male Subjects. |
| Lead sponsor | Pfizer, Industry |
| Collaborators | University of Adelaide Royal Adelaide Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral |
| Interventions | caloric restriction - 10%, caloric restriction - 25%, caloric restriction - 50%, caloric restriction - Control |
| Enrollment | 57 |
| Start date | Oct 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | Oct 3, 2006 |
| Last update posted | Mar 23, 2009 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: